---
schema_version: "secwatch.filing_event.v1"
accession: "0001636422-24-000116"
form_type: "8-K"
ticker: "HCAT"
cik: "0001636422"
company_name: "Health Catalyst, Inc."
filed_at: "2024-08-07T23:59:59+00:00"
generated_at: "2026-05-31T11:47:35.301096+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Health Catalyst beats Q2 2024 guidance: revenue $75.9M, Adj. EBITDA $7.5M

## Summary
- Total revenue $75.9M (+4% YoY); net loss $13.5M vs $32.6M loss in Q2 2023.
- Adjusted EBITDA $7.5M, exceeding guidance midpoint of $6.0M.
- Reiterates FY 2024 revenue $304-312M and Adj. EBITDA $24-26M; Q3 rev guidance $74.5-77.5M.
- Signed more net new platform subscription clients in 1H 2024 than all of 2023; targeting low-20s for FY.
- Announced $225M credit facility with Silver Point Finance and acquisitions of Carevive and Lumeon.

## SEC filing metadata
- accession: 0001636422-24-000116
- form_type: 8-K
- ticker: HCAT
- cik: 0001636422
- company_name: Health Catalyst, Inc.
- filed_at: 2024-08-07T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000116/0001636422-24-000116-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1636422/000163642224000116/hcat-20240807.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001636422-24-000116
- JSON: https://secwatch.observer/filing/0001636422-24-000116.json
- Plain text: https://secwatch.observer/filing/0001636422-24-000116.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.